SPP 635
Alternative Names: SPP 630; SPP 635Latest Information Update: 30 Jul 2010
At a glance
- Originator Speedel Experimenta
- Class Antihypertensives
- Mechanism of Action Renin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
- Discontinued End-organ damage
Most Recent Events
- 30 Jul 2010 No development reported - Phase-II for Hypertension in Germany (PO)
- 30 Jul 2010 No development reported - Phase-II for Hypertension in Ireland (PO)
- 09 Jul 2008 Speedel has been acquired by Novartis